The Cannes Lions International Festival of Creativity is known for its topical breadth – and the smart pharma marketers who ...

AbbVie has shared promising top-line results from a late-stage study of its JAK inhibitor Rinvoq (upadacitinib) in severe ...

In exchange, Hengrui will receive $500m in upfront fees and will be eligible for approximately $12bn in development, ...

Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account ...

In today’s digital age, misinformation spreads faster than ever, often driven by sensational headlines and influencer content ...

There’s a growing trend of LMS platforms leveraging AI to offer smart suggestions, automated assessments and adaptive ...

Novo Nordisk’s Alhemo (concizumab-mtci) has been approved by the US Food and Drug Administration (FDA) to prevent or reduce ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab) has shown continued benefit over four years, according ...

Yet this simple difference translated into a median progression-free survival (PFS) of 11.3 months versus 5.7 months for ...

Eli Lilly’s GIP/GLP-1 dual receptor agonist Mounjaro (tirzepatide) has demonstrated cardiovascular protection in a late-stage ...

The most widely used measure of health-related self-efficacy is the Patient Activation Measure (PAM). It is a ...

The new initiative, FDA PreCheck, was developed in response to President Donald Trump’s executive order to accelerate the ...